Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer.

There was a highly significant difference in survival prognosis between the high and low expression groups of AIFM1 (p-value < 0.01), with the low expression group having a better prognosis compared to the high expression group; There was a significant contrast in survival prognosis between the high and low expression groups of ATP7B (p-value < 0.05), with the high expression group showing better prognosis than the low expression group.

also in 132,142 other papers